A phase 2, multicenter, randomized, open-label study of a continuous hepatic arterial infusion combination therapy with OPC-18 and 5-FU versus the best salvage therapy (BST) in patients with highly advanced hepatocellular carcinoma

Authors
Category Primary study
JournalJapan Primary Registry Network
Year 2007
INTERVENTION: Intervention name : Interferon alpha‐nl Dosage And administration of the intervention : SC CONDITION: Advanced hepatocellular carcinoma PRIMARY OUTCOME: Efficacy/safety INCLUSION CRITERIA: Patients with highly advanced hepatocellular carcinoma for which resection therapy or local therapy is inapplicable due to advanced vascular invasion, patients with no remote metastasis (extrahepatic metastasis), patients who have not received intra‐arterial hepatic chemoembolization or systemic chemotherapy
Epistemonikos ID: 774cc2f193d1c712e0ad9a96fe5bc7cafefa5c6a
First added on: Aug 21, 2024